Table 2.
Increased expression of CD14 and CD32 but reduced expression of CD11b by H. pylori-infected M1 macrophages
Treatmenta | Surface molecule expression (median MFI)b |
||||||||
---|---|---|---|---|---|---|---|---|---|
CD11b | CD14 | CD16 | CD32 | CD64 | CD80 | CD86 | CD206 | HLA-DR | |
H. pylori | 17* (9, 21) | 52* (26, 72) | 2 (1, 4) | 44* (38, 47) | 0 (0, 2) | 12 (1, 14) | 6 (4, 8) | 21 (0, 26) | 25 (21, 40) |
LPS | 27 (13, 34) | 24 (18, 49) | 4 (2, 5) | 43 (37, 46) | 0 (0, 2) | 13* (3, 20) | 13 (9, 23) | 13 (0, 38) | 39 (30, 41) |
Medium | 61 (11, 81) | 12 (8, 18) | 3 (1, 6) | 32 (28, 37) | 1 (0, 3) | 1 (0, 3) | 12 (8, 18) | 33 (0, 64) | 47 (43, 63) |
H. pylori, infected with H. pylori; LPS, stimulated with LPS; medium, treated with medium only.
Values are based on at least six independent experiments (six donors). MFIs of isotype controls were subtracted. Values in parentheses are the 25th and 75th percentile MFIs, respectively.
, P < 0.05 (Friedman test and Dunn's multiple comparison test).